Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 237 member B (FAM237B) is a protein-coding gene originally misannotated as non-coding, now recognized as encoding a conserved secreted microprotein found across species including humans, mice, and chickens. FAM237B is expressed in the arcuate nucleus of the hypothalamus and is implicated in appetite regulation; in mice, knockout or central administration studies demonstrated an orexigenic effect (increased feeding), consistent with findings in chickens. Molecularly, it may activate the GPR83 receptor via GNAQ signaling. Disease associations are minimal but include possible involvement in Stickler syndrome at the gene level. Despite detectable extracellular protein expression, its role as a human drug target is unestablished, and no drugs, biomarkers, or safety profiles are known.
Not established for any approved drug; preclinical recombinant protein acts as an orexigenic factor via central administration in rodents, possibly activating GPR83/GNAQ signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 237 member B (FAM237B).